Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical Response
The findings advance the field of ex vivo screening and present an opportunity to combine strategies for functional precision medicine with comprehensive characterization of disease for improved treatment and future management of lung cancer.
Authors
- Anca Oniscu
- David Tamborero (ORCID: https://orcid.org/0000-0002-7218-2806)
- Marcus Skribek (ORCID: https://orcid.org/0000-0001-8692-6426)
- Katalin Dobra (ORCID: https://orcid.org/0000-0002-0207-6733)
- Olena Berkovska (ORCID: https://orcid.org/0000-0002-8811-0591)
- Andrey Alexeyenko (ORCID: https://orcid.org/0000-0001-8812-6481)
- Hanna Krynska (ORCID: https://orcid.org/0000-0002-3759-3503)
- Brinton A. Seashore-Ludlow (ORCID: https://orcid.org/0000-0001-8658-5967)
- Annica K. B. Gad (ORCID: https://orcid.org/0000-0002-1098-9129)
- Rita Ötvös
- Greta Gudoitytė (ORCID: https://orcid.org/0000-0003-1963-7856)
- Katharina Strauß
- Jenny Zipprick
Institutions
- Karolinska University Hospital (SE)
- BirdLife International (KE)
- Karolinska Institutet (SE)
- Integrated Cardio Metabolic Centre (SE)
Publication Details
- Journal
- Cancers
- Published
- 2025-07-16
- DOI
- https://doi.org/10.3390/cancers17142363
- Citations
- 1
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Radiumhemmets Forskningsfonder